249 related articles for article (PubMed ID: 24126882)
1. HIV and the heart: the impact of antiretroviral therapy: a global perspective.
Thienemann F; Sliwa K; Rockstroh JK
Eur Heart J; 2013 Dec; 34(46):3538-46. PubMed ID: 24126882
[TBL] [Abstract][Full Text] [Related]
2. Cardiac manifestations of HIV infection: an African perspective.
Ntsekhe M; Mayosi BM
Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):120-7. PubMed ID: 19104517
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in HIV-associated cardiovascular diseases in Africa.
Syed FF; Sani MU
Heart; 2013 Aug; 99(16):1146-53. PubMed ID: 23680889
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort.
Sliwa K; Carrington MJ; Becker A; Thienemann F; Ntsekhe M; Stewart S
Eur Heart J; 2012 Apr; 33(7):866-74. PubMed ID: 22048682
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and cardiovascular disease.
Hemkens LG; Bucher HC
Eur Heart J; 2014 Jun; 35(21):1373-81. PubMed ID: 24408888
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study.
Viciana P; Ocampo A; Hevia H; Palazuelos M; Ledesma F
AIDS Care; 2016 Oct; 28(10):1321-6. PubMed ID: 27140483
[TBL] [Abstract][Full Text] [Related]
7. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS.
Porche DJ
Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281
[TBL] [Abstract][Full Text] [Related]
8. Incidence of the involvement of the cardiovascular system in HIV infection.
Barbarinia G; Barbaro G
AIDS; 2003 Apr; 17 Suppl 1():S46-50. PubMed ID: 12870530
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated cardiovascular complications: a new challenge for emergency physicians.
Barbaro G; Fisher SD; Giancaspro G; Lipshultz SE
Am J Emerg Med; 2001 Nov; 19(7):566-74. PubMed ID: 11699002
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapies.
Owen WF
Clin Podiatr Med Surg; 1998 Apr; 15(2):227-39. PubMed ID: 9576051
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
12. Abacavir: a review of its clinical potential in patients with HIV infection.
Hervey PS; Perry CM
Drugs; 2000 Aug; 60(2):447-79. PubMed ID: 10983741
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1.
Shafer RW; Vuitton DA
Biomed Pharmacother; 1999 Mar; 53(2):73-86. PubMed ID: 10337461
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis and HIV co-infection: a practical therapeutic approach.
Breen RA; Swaden L; Ballinger J; Lipman MC
Drugs; 2006; 66(18):2299-308. PubMed ID: 17181373
[TBL] [Abstract][Full Text] [Related]
15. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy and resistance to antiretroviral drugs.
Lange JM; van Leeuwen R
Ethiop Med J; 2002 Apr; 40 Suppl 1():51-75. PubMed ID: 12802831
[TBL] [Abstract][Full Text] [Related]
17. Cardiac diastolic dysfunction is prevalent in HIV-infected patients.
Nayak G; Ferguson M; Tribble DR; Porter CK; Rapena R; Marchicelli M; Decker CF
AIDS Patient Care STDS; 2009 Apr; 23(4):231-8. PubMed ID: 19281430
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
[TBL] [Abstract][Full Text] [Related]
19. Delavirdine: a review of its use in HIV infection.
Scott LJ; Perry CM
Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019
[TBL] [Abstract][Full Text] [Related]
20. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
